Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis

Okuda, 1985, Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients, Gastroenterology, 89, 279, 10.1016/0016-5085(85)90327-0 Gaiani, 1991, Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopiccorrelation in 228 patients, Gastroenterology, 100, 160, 10.1016/0016-5085(91)90596-D Amitrano, 2004, Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis, J Hepatol, 40, 736, 10.1016/j.jhep.2004.01.001 Maruyama, 2013, De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes, Am J Gastroenterol, 108, 568, 10.1038/ajg.2012.452 Berry, 2015, Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis, Clin Gastroenterol Hepatol, 13, 585, 10.1016/j.cgh.2014.10.010 Nery, 2015, Causes and consequences of portal vein thrombosis in 1243 patients with cirrhosis: results of a longitudinal study, Hepatology, 61, 660, 10.1002/hep.27546 Mancuso, 2017, Classification of portal vein thrombosis in cirrhosis, Gastroenterology, 152, 1247, 10.1053/j.gastro.2016.09.067 Englesbe, 2010, Portal vein thrombosis and survival in patients with cirrhosis, Liver Transpl, 16, 83, 10.1002/lt.21941 Ravaioli, 2011, Portal vein thrombosis and liver transplantation: evaluation during 10 years of experience at the University of Bologna, Ann Surg, 253, 378, 10.1097/SLA.0b013e318206818b Francoz, 2005, Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation, Gut, 54, 691, 10.1136/gut.2004.042796 Amitrano, 2010, Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis, J Clin Gastroenterol, 44, 448, 10.1097/MCG.0b013e3181b3ab44 Senzolo, 2012, Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis, Liver Int, 32, 919, 10.1111/j.1478-3231.2012.02785.x Delgado, 2012, Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis, Clin Gastroenterol Hepatol, 10, 776, 10.1016/j.cgh.2012.01.012 Werner, 2013, Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation, Dig Dis Sci, 58, 1776, 10.1007/s10620-012-2548-y Chung, 2014, Safety, efficacy and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis, Clin Mol Hepatol, 20, 384, 10.3350/cmh.2014.20.4.384 Chen, 2016, Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis, Eur J Gastroenterol Hepatol, 28, 82, 10.1097/MEG.0000000000000482 Loffredo, 2017, Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis, Gastroenterology, 153, 480, 10.1053/j.gastro.2017.04.042 Ageno, 2015, Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry, JAMA Intern Med, 175, 1474, 10.1001/jamainternmed.2015.3184 de Franchis, 2015, Expanding consensus in portal hypertension. Report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 Villa, 2012, Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis, Gastroenterology, 143, 1253, 10.1053/j.gastro.2012.07.018 Dhar, 2017, Anticoagulation in chronic liver disease, J Hepatol, 66, 1313, 10.1016/j.jhep.2017.01.006 Cerini, 2015, Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study, Hepatology, 62, 575, 10.1002/hep.27783